10 Einträge von 84 mit conversion therapy
www.cslbehring.ch
Datum der Indexierung 08.01.2024 08:19:49
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords studies plasma | behring nouvelles | with savoir | that notre | disease plus | nous research | application including | products quality | investigator patients | initiated clinical |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, health economics in CIDP and specific sub-popu Therapy Use of C1-INH in special patient populations (eg; pregnancy, pediatrics) Hematology We seek to advance science and improve patient care with CSL Behring’s products in the field of hematology. Through total or partial fundi
Text Inhalt Text aus URL
Log Metriken 1036321
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords studies plasma | behring nouvelles | with savoir | that notre | disease plus | nous research | application including | products quality | investigator patients | initiated clinical |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, health economics in CIDP and specific sub-popu Therapy Use of C1-INH in special patient populations (eg; pregnancy, pediatrics) Hematology We seek to advance science and improve patient care with CSL Behring’s products in the field of hematology. Through total or partial fundi
Text Inhalt Text aus URL
Log Metriken 1036321
www.cslbehring.ch
Datum der Indexierung 21.01.2024 21:23:06
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords studies through | behring investigator-initiated | with nouvelles | that plus | disease notre | nous research | initiated including | patients quality | clinical products | application investigator |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, health economics in CIDP and specific sub-popu Therapy Use of C1-INH in special patient populations (eg; pregnancy, pediatrics) Hematology We seek to advance science and improve patient care with CSL Behring’s products in the field of hematology. Through total or partial fundi
Text Inhalt Text aus URL
Log Metriken 1036321
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords studies through | behring investigator-initiated | with nouvelles | that plus | disease notre | nous research | initiated including | patients quality | clinical products | application investigator |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, health economics in CIDP and specific sub-popu Therapy Use of C1-INH in special patient populations (eg; pregnancy, pediatrics) Hematology We seek to advance science and improve patient care with CSL Behring’s products in the field of hematology. Through total or partial fundi
Text Inhalt Text aus URL
Log Metriken 1036321
www.cslbehring.ch
Datum der Indexierung 15.01.2024 02:32:16
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords studies through | behring investigator-initiated | with nouvelles | that plus | disease notre | nous research | initiated including | patients quality | clinical products | application investigator |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, health economics in CIDP and specific sub-popu Therapy Use of C1-INH in special patient populations (eg; pregnancy, pediatrics) Hematology We seek to advance science and improve patient care with CSL Behring’s products in the field of hematology. Through total or partial fundi
Text Inhalt Text aus URL
Log Metriken 1036321
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords studies through | behring investigator-initiated | with nouvelles | that plus | disease notre | nous research | initiated including | patients quality | clinical products | application investigator |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, health economics in CIDP and specific sub-popu Therapy Use of C1-INH in special patient populations (eg; pregnancy, pediatrics) Hematology We seek to advance science and improve patient care with CSL Behring’s products in the field of hematology. Through total or partial fundi
Text Inhalt Text aus URL
Log Metriken 1036321
www.cslbehring.ch
Datum der Indexierung 10.01.2024 05:07:55
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords studies through | behring investigator-initiated | with nouvelles | that plus | disease notre | nous research | initiated including | patients quality | clinical products | application investigator |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, health economics in CIDP and specific sub-popu Therapy Use of C1-INH in special patient populations (eg; pregnancy, pediatrics) Hematology We seek to advance science and improve patient care with CSL Behring’s products in the field of hematology. Through total or partial fundi
Text Inhalt Text aus URL
Log Metriken 1036321
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords studies through | behring investigator-initiated | with nouvelles | that plus | disease notre | nous research | initiated including | patients quality | clinical products | application investigator |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, health economics in CIDP and specific sub-popu Therapy Use of C1-INH in special patient populations (eg; pregnancy, pediatrics) Hematology We seek to advance science and improve patient care with CSL Behring’s products in the field of hematology. Through total or partial fundi
Text Inhalt Text aus URL
Log Metriken 1036321
www.cslbehring.ch
Datum der Indexierung 08.01.2024 08:22:21
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords behring areas | with including | studies diseases | that health | disease learn | products research | clinical your | more patients | application quality | initiated investigator |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, health economics in CIDP and specific sub-popu therapy in many areas of treatment. Learn More We also aim to make sure that nothing holds you back from getting the therapies you need. Learn More R&D R&D Investigator Initiated Studies Our product portfolio focuses on innovation
Text Inhalt Text aus URL
Log Metriken 1036330
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords behring areas | with including | studies diseases | that health | disease learn | products research | clinical your | more patients | application quality | initiated investigator |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, health economics in CIDP and specific sub-popu therapy in many areas of treatment. Learn More We also aim to make sure that nothing holds you back from getting the therapies you need. Learn More R&D R&D Investigator Initiated Studies Our product portfolio focuses on innovation
Text Inhalt Text aus URL
Log Metriken 1036330
www.cslbehring.ch
Datum der Indexierung 15.01.2024 02:34:58
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords behring areas | with including | studies learn | that diseases | disease research | products health | clinical your | initiated more | application patients | investigator quality |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, health economics in CIDP and specific sub-popu therapy in many areas of treatment. Learn More We also aim to make sure that nothing holds you back from getting the therapies you need. Learn More R&D R&D Investigator Initiated Studies Our product portfolio focuses on innovation
Text Inhalt Text aus URL
Log Metriken 1036330
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords behring areas | with including | studies learn | that diseases | disease research | products health | clinical your | initiated more | application patients | investigator quality |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, health economics in CIDP and specific sub-popu therapy in many areas of treatment. Learn More We also aim to make sure that nothing holds you back from getting the therapies you need. Learn More R&D R&D Investigator Initiated Studies Our product portfolio focuses on innovation
Text Inhalt Text aus URL
Log Metriken 1036330
www.cslbehring.ch
Datum der Indexierung 10.01.2024 05:10:09
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords behring areas | with including | studies learn | that diseases | disease research | products health | clinical your | initiated more | application patients | investigator quality |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, health economics in CIDP and specific sub-popu therapy in many areas of treatment. Learn More We also aim to make sure that nothing holds you back from getting the therapies you need. Learn More R&D R&D Investigator Initiated Studies Our product portfolio focuses on innovation
Text Inhalt Text aus URL
Log Metriken 1036330
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords behring areas | with including | studies learn | that diseases | disease research | products health | clinical your | initiated more | application patients | investigator quality |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, health economics in CIDP and specific sub-popu therapy in many areas of treatment. Learn More We also aim to make sure that nothing holds you back from getting the therapies you need. Learn More R&D R&D Investigator Initiated Studies Our product portfolio focuses on innovation
Text Inhalt Text aus URL
Log Metriken 1036330
www.cslbehring.ch
Datum der Indexierung 21.01.2024 21:25:55
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords behring areas | with including | studies learn | that diseases | disease research | products health | clinical your | initiated more | application patients | investigator quality |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, health economics in CIDP and specific sub-popu therapy in many areas of treatment. Learn More We also aim to make sure that nothing holds you back from getting the therapies you need. Learn More R&D R&D Investigator Initiated Studies Our product portfolio focuses on innovation
Text Inhalt Text aus URL
Log Metriken 1036330
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords behring areas | with including | studies learn | that diseases | disease research | products health | clinical your | initiated more | application patients | investigator quality |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, health economics in CIDP and specific sub-popu therapy in many areas of treatment. Learn More We also aim to make sure that nothing holds you back from getting the therapies you need. Learn More R&D R&D Investigator Initiated Studies Our product portfolio focuses on innovation
Text Inhalt Text aus URL
Log Metriken 1036330
www.cslbehring.ch
Datum der Indexierung 08.01.2024 08:26:05
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords studies news | with through | behring support | that factor | disease high | initiated erfahren | application mehr | investigator quality | clinical including | products research |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, health economics in CIDP and specific sub-popu Therapy Use of C1-INH in special patient populations (eg; pregnancy, pediatrics) Hematology We seek to advance science and improve patient care with CSL Behring’s products in the field of hematology. Through total or partial fundi
Text Inhalt Text aus URL
Log Metriken 1036337
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords studies news | with through | behring support | that factor | disease high | initiated erfahren | application mehr | investigator quality | clinical including | products research |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, health economics in CIDP and specific sub-popu Therapy Use of C1-INH in special patient populations (eg; pregnancy, pediatrics) Hematology We seek to advance science and improve patient care with CSL Behring’s products in the field of hematology. Through total or partial fundi
Text Inhalt Text aus URL
Log Metriken 1036337
www.cslbehring.ch
Datum der Indexierung 21.01.2024 21:20:17
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords studies news | with patients | behring mehr | that through | disease support | products factor | initiated high | clinical research | investigator quality | application including |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, health economics in CIDP and specific sub-popu Therapy Use of C1-INH in special patient populations (eg; pregnancy, pediatrics) Hematology We seek to advance science and improve patient care with CSL Behring’s products in the field of hematology. Through total or partial fundi
Text Inhalt Text aus URL
Log Metriken 1036325
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords studies news | with patients | behring mehr | that through | disease support | products factor | initiated high | clinical research | investigator quality | application including |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
conversion from intravenous immunoglobulins (IVIg) to subcutaneous immunoglobulins (SCIg), loading dose and dosing by body mass index (BMI) or fat percent versus weight, quality-of-life in CIDP patients, health economics in CIDP and specific sub-popu Therapy Use of C1-INH in special patient populations (eg; pregnancy, pediatrics) Hematology We seek to advance science and improve patient care with CSL Behring’s products in the field of hematology. Through total or partial fundi
Text Inhalt Text aus URL
Log Metriken 1036325